Showing results (91-100 of 984) with videos related to
Sort By:
Pageof 99
Progress in Cardiovascular Diseases|December 1, 2001
Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromesD P Chew, M Roffi, E J TopolHeart & Lung : the Journal of Critical Care|November 1, 1989
Exercise capacity in patients 3 days after acute, uncomplicated myocardial infarctionK A Burek, J Kirscht, E J TopolAmerican Heart Journal|November 1, 1989
The cost:benefit ratio of acute intervention for myocardial infarction: results of a prospective, matched pair analysisA T Chapekis, K Burek, E J TopolClinical Cardiology|May 1, 1996
Antiplatelet and anticoagulant use after myocardial infarctionG T Almony, J Lefkovits, E J TopolHuman Molecular Genetics|August 24, 2012
Cystic fibrosis in an era of genomically guided therapyP M Barrett, A Alagely, E J TopolJournal of the American College of Cardiology|September 1, 1997
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesR D Anderson, E M Ohman, D R Holmes, et al.Journal of the American College of Cardiology|June 11, 1992
Abrupt vessel closure after directional coronary atherectomy. The U.S. Directional Atherectomy Investigator GroupJ J Popma, E J Topol, T Hinohara, et al.Progress in Cardiovascular Diseases|November 5, 1997
Stenting for ischemic heart diseaseG Belli, S G Ellis, E J TopolCirculation|April 1, 1995
A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II InvestigatorsD R Holmes, E J Topol, R M Califf, et al.The American Journal of Cardiology|March 1, 1993
Quantitative analysis of factors influencing late lumen loss and restenosis after directional coronary atherectomyJ J Popma, N B De Cesare, C A Pinkerton, et al.Pageof 99